CS
JAZZ icon

Comerica Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History

Comerica Securities’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-230
Closed -$36.6K – 944
2022
Q4 		$36.6K Buy
+230
New +$33.7K ﹤0.01% 794
2020
Q1 		– Sell
-9,923
Closed -$1.48M – 439
2019
Q4 		$1.48M Buy
9,923
+1,645
+20% +$224K 0.14% 155
2019
Q3 		$1.06M Buy
+8,278
New +$1.11M 0.11% 177
2017
Q1 		– Sell
-6,145
Closed -$1.01M – 412
2016
Q4 		$1.01M Buy
+6,145
New +$684K 0.25% 101
2016
Q1 		– Sell
-1,921
Closed -$270K – 359
2015
Q4 		$270K Sell
1,921
-3,289
-63% -$456K 0.07% 278
2015
Q3 		$692K Sell
5,210
-841
-14% -$145K 0.19% 127
2015
Q2 		$1.06M Buy
6,051
+1,337
+28% +$240K 0.26% 107
2015
Q1 		$815K Sell
4,714
-1,431
-23% -$246K 0.21% 120
2014
Q4 		$1.01M Sell
6,145
-2,647
-30% -$439K 0.31% 85
2014
Q3 		$1.41M Buy
8,792
+6,516
+286% +$1M 0.47% 66
2014
Q2 		$335K Sell
2,276
-886
-28% -$123K 0.3% 79
2014
Q1 		$439K Buy
3,162
+1,477
+88% +$222K 0.42% 52
2013
Q4 		$213K Buy
+1,685
New +$174K 0.22% 91

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Comerica Securities's JAZZ Position: Q1 2023 in Review

Comerica Securities sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2023, closing a stake of 230 shares — an estimated $36.6K sold.

Comerica Securities first reported a position in JAZZ in Q4 2013 and held it in 13 quarters. The position peaked at $1.48M in Q4 2019. 471 funds tracked by Wall St. Rank hold JAZZ as of Q1 2023.

  • Comerica Securities reported no remaining Jazz Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Comerica Securities sold 230 Jazz Pharmaceuticals shares in Q1 2023, an estimated $36.6K.
  • Comerica Securities first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 13 quarters.
  • Comerica Securities's Jazz Pharmaceuticals position peaked at $1.48M in Q4 2019.
  • 471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.